Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-021783

Director sold 59,621 shares at an average $10.80 ($644,048)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-06-02 Sale : show line 1 in the form −41,193 $10.79 $444,472 4,422,734 I
2016-06-03 Sale : show line 2 in the form −18,428 $10.83 $199,575 4,404,306 I
Open-market sales · 59,621 sh · avg $10.80 · $644,048
Loading xslF345X03/doc4.xml…